Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases | Heart

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Review

Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Gulsin GS, Graham-Brown MPM, Squire IB, et al

Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases

Heart 2022;108:16-21.